Neurofilament light chain (NEFL) can be used to detect risk for ALS disease conversion in at‐risk individuals carrying ALS‐causing mutations, such as SOD1 pathogenic variants6 and is elevated in ALS due to C9orf72 repeat expansions.7 Here, C9orf72 is linked to amyotrophic lateral sclerosis.